Advanced Search
ZHENG Deng-yun, MAI Da-hai, HE Zhi-jiang. An Analysis of the Effects in the Treatment of Advanced Stage Gastric Carcinoma through Arterial Perfusion by means of FAM Program[J]. Cancer Research on Prevention and Treatment, 2000, 27(05): 406-407. DOI: 10.3971/j.issn.1000-8578.2447
Citation: ZHENG Deng-yun, MAI Da-hai, HE Zhi-jiang. An Analysis of the Effects in the Treatment of Advanced Stage Gastric Carcinoma through Arterial Perfusion by means of FAM Program[J]. Cancer Research on Prevention and Treatment, 2000, 27(05): 406-407. DOI: 10.3971/j.issn.1000-8578.2447

An Analysis of the Effects in the Treatment of Advanced Stage Gastric Carcinoma through Arterial Perfusion by means of FAM Program

More Information
  • Received Date: December 31, 1899
  • Revised Date: December 31, 1899
  • Objective The purpose of the research is to compare the effects in the treatment of advanced stage gastric carcinoma respectively by arterial perfusion and by intravenous injection with FAM program. Methods Forty three patients with advanced stage gastric carcinoma were randomly divided into two groups.Both groups,given approximately the same dosages,were treated with FAM program.Twenty two patients were in the arterial perfusion group and twenty one were in the intravenous injection group. Results The general alleviation rate for the arterial perfusion group was 18.2%(4/22) and the overall effective rate was 68.2%(15/22),while the general alleviation rate for the intravenous injection group was 9.5%(2/21) and the overall effective rate was 38.1%(8/21).The difference between the overall effective rates of the two groups was significant (χ2=3.9031;P<0.05).The subsistence periods of two groups were respectively 8 months and 6.5months without any statistic significance.In terms of the inhibition rate on bone marrow,the two groups had no difference.Besides,the patients just had very slight gastric and intestinal reactions. Conclusion The arterial perfusion group treated with FAM program for advanced staged gastric carcinoma had higher local control rate than the intravenous injection group,but the two groups had no significant difference in subsistence period
  • Related Articles

    [1]WU Mingzhe, WANG Fuchun, PAN Haojie, ZHOU An'an, XIAO Xi, TIAN Junqiang. Progress of Different Programmed Cell Death Pathways in Kidney Cancer[J]. Cancer Research on Prevention and Treatment, 2023, 50(5): 531-537. DOI: 10.3971/j.issn.1000-8578.2023.22.1100
    [2]ZHANG Rui-ping, MA Yong-quan, WANG Qing-kang. Study on the effects of DMF and FAM regimens in the treatment of advanced gastric cancer[J]. Cancer Research on Prevention and Treatment, 2000, 27(04): 290-292. DOI: 10.3971/j.issn.1000-8578.1304
    [3]Zheng Qu bin, Yang Weizhu, Jiang Na, . Observation on Therapeutic Effectin the Treatment of rectal cancer with Selective Arterial Drug perfusion[J]. Cancer Research on Prevention and Treatment, 1999, 26(3): 219-221.
    [4]Zheng Qubin, Yang Weizhu, Jiang Na, . Observation on Therapeutic Effect in the Treatment of Rectal Cancer with Selective Arterial Drug Perfusion[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 136-139.
    [5]Sun Jianwei, . Preoperative intra-arterial lnfusion chemotherapy in the treatment of advanced grastric Cancer[J]. Cancer Research on Prevention and Treatment, 1998, 25(6): 485-486.
    [6]Wu Jiang, . Treatment of Advanced Primary Hepatocellular Carcinoma with low dose of and FM or FAM[J]. Cancer Research on Prevention and Treatment, 1998, 25(1): 52-54.
    [7]Wu Hut, . Analysisleucovorinof the short-term efficacy about high-doseand 5-Fu basedcombination coinadvanced gastricpared withFAM regimen in treatingcarcinoma[J]. Cancer Research on Prevention and Treatment, 1997, 24(3): 174-175.
    [10]Yong xueLi, . A PROTOCOI OF FAM TYPE FOR TREATMENT OF GRADE IV CASTRIC CARCIONMA-AN ANAIYSIS OF 30 CASES[J]. Cancer Research on Prevention and Treatment, 1991, 18(1): 41-43.

Catalog

    Article views (2125) PDF downloads (586) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return